Complement Modulation Mitigates Inflammation-Mediated Preterm Birth and Fetal Neural Inflammation
Cells · 2025
DOI: 10.3390/cells14141045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Eliza R McElwee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. Hauptthemen laut MEDLINE: Premature Birth, Inflammation, Fetus, Complement System Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, BLRD VA.
Abstract (Originalsprache)
Preterm birth and the neonatal pathological sequelae that follow spontaneous preterm labor are closely associated with maternal and fetal inflammatory activation. Previous studies have indicated a role for the complement system in this inflammatory response. Utilizing an LPS inflammation-induced model of preterm birth, we investigated various delivery outcomes and their correlation with complement activation products within cervical, uterine, and fetal brain tissue after administration of LPS. We provide further evidence that complement-mediated inflammation within cervical and uterine tissue contributes to aberrant cellular changes and an increase in preterm delivery. We additionally show that a targeted complement inhibitor that specifically targets to sites of complement activation (CR2-Crry) mitigates the effects of LPS-induced pathology and preterm birth. Complement inhibition increased latency to delivery, mean gestational age at delivery, and average number of viable pups. Furthermore, the improved delivery outcomes seen with CR2-Crry treatment correlated with a reduced inflammatory response in maternal tissue and in fetal brain tissue in terms of reduced complement activation, reduced pro-inflammatory cytokines, and reduced macrophage recruitment. These data indicate that complement inhibition represents a potential therapeutic strategy for preventing preterm birth. The localization of complement inhibition by a site-targeting approach reduces the possibility of unwanted off-target effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
- Department of Pharmacology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
- Department of Neurological Surgery, Division of Pediatrics, Medical University of South Carolina, Charleston, SC 29425, USA.
- College of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
- Ralph Johnson VA Medical Center, Charleston, SC 29425, USA.
ORCID-Profile: Khalil Mallah, Stephen Tomlinson
Förderung
- NIH HHS
- NIDDK NIH HHS
- BLRD VA
- NIGMS NIH HHS
- NCATS NIH HHS
- RRD VA
- U.S. Department of Veteran's Affairs
- NCI NIH HHS
Zitieren
APA
McElwee, E. R., Hatchell, D., Alshareef, M., Mallah, K., Hall, H., Robinson, H., Eskandari, R., Chang, E., Sullivan, S., & Tomlinson, S. (2025). Complement Modulation Mitigates Inflammation-Mediated Preterm Birth and Fetal Neural Inflammation. Cells. https://doi.org/10.3390/cells14141045
Vancouver
McElwee ER, Hatchell D, Alshareef M, Mallah K, Hall H, Robinson H, et al. Complement Modulation Mitigates Inflammation-Mediated Preterm Birth and Fetal Neural Inflammation. Cells. 2025. doi:10.3390/cells14141045
BibTeX
@article{McElwee2025,
author = {McElwee, Eliza R and Hatchell, Devin and Alshareef, Mohammed and Mallah, Khalil and Hall, Harriet and Robinson, Hannah and Eskandari, Ramin and Chang, Eugene and Sullivan, Scott and Tomlinson, Stephen},
title = {Complement Modulation Mitigates Inflammation-Mediated Preterm Birth and Fetal Neural Inflammation},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14141045}
}
EUVIMED